FDA Inspection
Cipla LimitedCipla Limited – FDA Inspection, Apr 13, 2018
Record Details
This FDA Inspection record concerns Cipla Limited, with an inspection on April 13, 2018, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · e8143ba3-08be-4081-940c-dd76d60ee6da
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1048005
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
Other FDA inspections of Cipla Limited
8| Date | Classification | Office | Project area |
|---|---|---|---|
| August 25, 2026 | Not classified | Office of Inspections and Investigations | |
| February 17, 2023 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| May 17, 2019 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| June 23, 2017 | Not classified | Office of Inspections and Investigations | Generic Drug Evaluation |
| January 27, 2017 | Not classified | Office of Inspections and Investigations |
Other documents for Cipla Limited
- FDA Inspection 1331746 - 2026-08-25
- FDA Inspection 1198343 - 2023-02-17
- FDA Inspection 1094880 - 2019-05-17
- FDA Inspection 1019068 - 2017-06-23
- FDA Inspection 1007876 - 2017-01-27
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.